Home
About
Overview
Management
Board of Directors
Advisors & Consultants
Technology
Overview
Commercial Applications
Videos
Research
Patent Portfolio
Consumer Products
Licensing Opportunities
Investors
Overview
News & Events
Presentations
Company Info
Analyst Coverage
Financial Info
Stock Data
SEC Filings
SEDAR
Legend Removal
Governance
Education
Background
Resources
General FAQs
Contact
News & Events
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Presentations
Company Info
Overview
Management Team
Contacts
2022 Annual General Meeting
FAQ
Analyst Coverage
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
SEDAR
Legend Removal
Governance
Board of Directors
Governance Documents
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Recent News
View All News
Apr 21, 2022 9:05am EDT
Lexaria Granted Patent for Use of DehydraTECH to Deliver Antiviral Drugs
Apr 19, 2022 9:05am EDT
Lexaria Commences Multi-Week Human Clinical Hypertension Study
View All News
Upcoming Events
View IR Calendar
May 31, 2022 1:00 pm PDT
2022 Annual Meeting of Shareholders
Jun 7 – Jun 9, 2022
LD Micro Invitational XXII
View IR Calendar
Email Alerts
Sign up for email alerts for Press Releases & SEC Filings
Sign Up
Email Alerts
Contacts
RSS News Feed
